Effect of immunization with herpes simplex virus type-1 (HSV-1) glycoprotein D (gD) plus the immune enhancer GPI-0100 on infection with HSV-1 or HSV-2

Vaccine

Volumn 24, Issue 10, 2006, Pages 1515-1522

  Quenelle, Debra C ^a   Collins, Deborah J ^a   Marciani, Dante J ^b   Kern, Earl R ^a  

^a University of Alabama at Birmingham   (United States)

^b Avantogen   (United States)

Author keywords

Adjuvant; Animal model; Human herpes simplex virus (HSV); Vaccine glycoprotein

Indexed keywords

GLYCOPROTEIN D; GPI 0100; HERPES SIMPLEX VACCINE; POLYSORBATE 40; SAPONIN DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; DISEASE SEVERITY; DRUG EFFECT; DRUG FORMULATION; FEMALE; GENITAL TRACT INFECTION; GUINEA PIG; HERPES; HERPES LABIALIS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; IMMUNITY; IMMUNIZATION; INOCULATION; MORTALITY; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTECTION; QUILLAJA; SCORING SYSTEM; VIRUS INFECTION; VIRUS REPLICATION; VIRUS SHEDDING; VIRUS STRAIN;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, VIRAL; DISEASE MODELS, ANIMAL; FEMALE; GUINEA PIGS; HERPES GENITALIS; HERPES SIMPLEX; HERPES SIMPLEX VIRUS VACCINES; IMMUNIZATION; MICE; SAPONINS; VIRAL ENVELOPE PROTEINS;

EID: 32544434934     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.10.017     Document Type: Article

References (42)

1. D.T. Fleming, G.M. McQuillam, R.E. Johnson, A.J. Nahmias, S.O. Aral, and F.K. Lee Herpes simplex virus type 2 in the United States, 1976 to 1994 N Engl J Med 337 16 1997 1105 1111
2. S.L. Sacks, P.D. Griffiths, L. Corey, C. Cohen, A. Cunningham, and G. Dusheiko HSV-2 transmission Antiviral Res 63 2004 S27 S35
3. D.I. Bernstein, L.R. Stanberry, S. Sacks, N.K. Ayisi, Y.H. Gong, and J. Ireland Evaluations of unformulated and formulated dendrimer-based microbicide candidates in mouse and guinea pig models of genital herpes Antimicrob Agents Chemother 47 12 2003 3784 3788
4. N. Bourne, L.R. Stanberry, E.R. Kern, G. Holan, B. Matthews, and D.I. Bernstein Dendrimers, a new class of candidate topical microbicides with activity against herpes simplex virus infection Antimicrob Agents Chemother 44 9 2000 2471 2474
5. E.R. Kern, J. Palmer, G. Szczech, G. Painter, and K.Y. Hostetler Efficacy of topical acyclovir monophosphate, acyclovir, or penciclovir in orofacial HSV-1 infections of mice and genital HSV-2 infections of guinea pigs Nucleosides Nucleotides Nucleic Acids 19 2000 501 513
6. S.L. Spruance, D.J. Freeman, and N.V. Sheth Comparison of topically applied 5-ethyl-2′- deoxyuridine and acyclovir in the treatment of cutaneous herpes simplex virus infection in guinea pigs Antimicrob Agents Chemother 28 1 1985 103 106
7. S.L. Spruance, M. McKeough, K. Sugibayashi, F. Robertson, P. Gaede, and D.S. Clark Effect of azone and propylene glycol on penetration of trifluorothymidine through skin and efficacy of different topical formulations against cutaneous herpes simplex virus infections in guinea pigs Antimicrob Agents Chemother 26 6 1984 819 823
8. S.L. Spruance, S.K. Tyring, M.H. Smith, and T.C. Meng Application of a topical immune response modifier, resiquimod gel to modify the recurrence rate of recurrent genital herpes: a pilot study J Infect Dis 184 2 2001 196 200
9. N. Bourne, R.B. Pyles, D.I. Bernstein, and L.R. Stanberry Modification of primary and recurrent genital herpes in guinea pigs by passive immunization J Gen Virol 83 2002 2797 2801
10. D.J. Freeman, M.B. McKeough, and S.L. Spruance Recombinant human interferon-alpha A treatment of an experimental cutaneous herpes simplex virus type 1 infection of guinea pigs J Interferon Res 7 2 1987 213 222
11. G.N. Milligan, K.L. Dudley-McClain, C.F. Chu, and C.G. Young Efficacy of genital T cell responses to herpes simplex virus type 2 resulting from immunization of the nasal mucosa Virology 318 2004 507 515
12. M.B. Parr, and E.L. Parr Intravaginal administration of herpes simplex virus type 2 to mice leads to infection of several neural and extraneural sites J Neurobiol 9 6 2003 594 602
13. L.R. Stanberry, A.L. Cunningham, A. Mindel, L.L. Scott, S.L. Spruance, and F.Y. Aoki Prospects for control of herpes simplex virus disease through immunization Clin Infect Dis 30 2000 549 566
14. N. Bourne, F.J. Bravo, M. Francotte, D.I. Bernstein, M.G. Myers, and M. Slaoui Herpes simplex virus (HSV) type 2 glycoprotein D subunit vaccines and protection against genital HSV-1 or HSV-2 disease in guinea pigs J Infect Dis 187 2003 542 549
15. T. Heineman, L. Pesnicak, M. Ali, T. Krogmann, N. Krudwig, and J.I. Cohen Varicella-zoster virus expressing HSV-2 glycoproteins B and D induces protection against HSV-2 challenge Vaccine 22 2004 2558 2565
16. T.J. Higgins, K.M. Herold, R.L. Arnold, S.P. McElhiney, K.E. Shroff, and C.J. Pachuk Plasmid DNA-expressed secreted and nonsecreted forms of herpes simplex virus glycoprotein D2 induce different types of immune responses JID 182 2000 1311 1320
17. C.A. Jones, and A.L. Cunningham Vaccination strategies to prevent genital herpes and neonatal herpes simplex virus (HSV) disease Herpes 11 1 2004 12 17
18. D.M. Koelle, and L. Corey Recent progress in herpes simplex virus immunobiology and vaccine research Clin Microbiol Rev 16 2003 96 113
19. R.B. Pyles, D. Higgins, C. Chalk, A. Zalar, J. Eiden, and C. Brown Use of immunostimulatory sequence-containing oligonucleotides as topical therapy for genital herpes simplex virus type 2 infection J Virol 76 22 2002 11387 11396
20. L.R. Stanberry, S.L. Spruance, A.L. Cunningham, D.I. Bernstein, A. Mindel, and S. Sacks Glycoprotein-D adjuvant vaccine to prevent genital herpes N Engl J Med 347 21 2002 1652 1661
21. C.A. Meseda, F. Schmeisser, R. Pedersen, A. Woerner, and J.P. Weir DNA immunization with a herpes simplex virus 2 bacterial artificial chromosome Virology 318 1 2003 420 428
22. F.C. Spector, E.R. Kern, J. Palmer, R. Kaiwar, T.A. Cha, and P. Brown Evaluation of a live attenuated recombinant virus RAV 9395 as a herpes simplex virus type 2 vaccine in guinea pigs J Infect Dis 177 1998 1143 1154
23. Ptak RG, May RD, Voss TG, Marciani DJ. Sustained protective immunity against herpes simplex virus type 1 (HSV-1) infection in mice with a glycoprotein D subunit vaccine. In: Proceedings of the fifteenth conference on antiviral research, International Society for Antiviral Research, Prague, Czech Republic, 2002 (poster A76).
24. Quenelle DC, Collins DJ, Marciani DJ, May RD, Kern ER. Effect of immunization with herpes simplex virus type 1 (HSV-1) glycoprotein D (gD) plus the immune enhancer GPI-0100 on infection with HSV-1 or HSV-2. In: Proceedings of the fifteenth conference on antiviral research, International Society for Antiviral Research, Prague, Czech Republic, 2002, (poster A77).
25. D.J. Marciani Vaccine adjuvants: role and mechanisms of action in vaccine immunogenicity Drug Discov Today 8 20 2003 934 943
26. J.B. Press, R.C. Reynolds, R.D. May, and D.J. Marciani Structure/function relationships of immunostimulating saponins Stud Nat Prod Chem 24 2000 131 174
27. D.J. Marciani, J.B. Press, R.C. Reynolds, A.K. Pathak, V. Pathak, and L.E. Gundy Development of semisynthetic triterpenoid saponin derivatives with immune stimulating activity Vaccine 18 2000 3141 3151
28. Y. Hoshino, S.K. Dalai, K. Wang, L. Pesnicak, T.Y. Lau, and D.M. Knipe Comparative efficacy and immunogenicity of replication-defective, recombinant glycoprotein, and DNA vaccines for herpes simplex virus 2 infections in mice and guinea pigs J Virol 79 2005 410 418
29. M.N. Prichard, R. Kaiwar, W.T. Jackman, D.C. Quenelle, D.J. Collins, and E.R. Kern Evaluation of AD472, a live attenuated recombinant herpes simplex virus type 2 vaccine in guinea pigs Vaccine 23 2005 5424 5431
30. D.I. Bernstein, and J.C. Kappes Enhanced in vitro reactivation of latent herpes simplex virus from neural and peripheral tissues with hexamethylenebisacetamide Arch Virol 99 1988 57 65
31. R.B. Smeltz, J. Chen, R. Ehrhardt, and E.M. Shevach Role of IFN-gamma in Th1 differentiation: IFN-gamma regulates IL-18R alpha expression by preventing the negative effects of IL-4 and by inducing/maintaining IL-12 receptor beta 2 expression J Immunol 168 12 2002 6165 6172
32. A.W. Wheeler, J.S. Marshall, and J.T. Ulrich A Th1-inducing adjuvant, MPL, enhances antibody profiles in experimental animals suggesting it has the potential to improve the efficacy of allergy vaccines Int Arch Allergy Immunol 126 2 2001 135 139
33. T.K. Varma, C.Y. Lin, T.A. Toliver-Kinsky, and E.R. Sherwood Endotoxin-induced gamma interferon production: contributing cell types and key regulatory factors Clin Diagn Lab Immunol 9 3 2002 530 543
34. D.J. Marciani, R.C. Reynolds, A.K. Pathak, K. Finley-Woodman, and R.D. May Fractionation, structural studies and immunological characterization of the semi-synthetic Quillaja saponins derivative GPI-0100 Vaccine 21 2003 3961 3971
35. D.J. Marciani, R.G. Ptak, T.C. Voss, R.C. Reynolds, A.K. Pathak, and T.L. Chamblin Degradation of Quillaja saponaria Molina saponins: loss of the protective effects of a herpes simplex virus 1 subunit vaccine Int Immunopharmacol 2 2002 1703 1711
36. S.F. Slovin, G. Ragupathi, C. Fernandez, M.P. Jefferson, M. Diani, and A.S. Wilton A bivalent conjugate vaccine in the treatment of biochemically relapsed prostate cancer: a study of glycosylated MUC-2-KLH and Globo H-KLH conjugate vaccines given with the new semi-synthetic saponin immunological adjuvant GPI-0100 or QS-21 Vaccine 23 24 2005 3114 3122
37. D.E. Jones, J.M. Palmer, A.D. Burt, C. Walker, A.J. Robe, and J.A. Kirby Bacterial motif DNA as an adjuvant for the breakdown of immune self-tolerance to pyruvate dehydrogenase complex Hepatology 36 3 2002 2679 2686
38. T. Sacher, P. Knolle, P. Nitchterlein, B. Arnold, G.J. Hammerling, and A. Limmer CpG- ODN-induced inflammation is sufficient to cause T cell-mediated autoaggression against hepatocytes Eur J Immunol 32 12 2002 3268 3637
39. J.H. Anders, B. Banas, and D. Schlondorff Signaling danger: toll-like receptors and their potential roles in kidney disease J Am Soc Nephrol 15 2004 854 867
40. P.S. Patole, H.J. Grone, S. Segerer, R. Ciubar, E. Belemezova, and A. Henger Viral double-stranded RNA aggravates lupus nephritis through toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells J Am Soc Nephrol 16 2005 1326 1338
41. Y.H. Chang, C.M. Pearson, and L. Chedid Adjuvant polyarthritis V induction by N-acetylmuramyl-l-alanyl-d-isoglutamine, the smallest peptide subunit of bacterial peptidoglycan J Exp Med 153 4 1981 1021 1026
42. Mossman S, Evans L, Baldridge JR, Evans JT. Immunostimulant compositions comprising aminoalkyl glucosaminide phosphates and saponins. US Patent Application 20,030,190,333 (2003).